Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | Ethyl chloroformate | HCID 10928 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | 4,9-dihydro-10H-thieno[3,4-b][1,5]benzodiazepin-10-one | HCID 12521641 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 13282023 | HCID 13282023 | — |
Reaction Steps
A quantity of 1.1 gm of ethyl chloroformate was added dropwise at 0° C. at a suspension of 1.57 gm (10 mmol) of 1-methyl-4-piperidinyl)acetic acid in 20 ml of tetrahydrofuran. Then, 2.16 gm (10 mmol) of 4,9-dihydro-10H-thieno-[3,4-b][1,5]benzodiazepin-10-one were added to the resulting suspension, which was then stirred for one hour at 0° C. and for a further four hours at ambient temperature. The suspension was then poured onto 160 ml of 2 N sodium hydroxide solution and extracted with toluene, and the organic phase was concentrated to dryness. After purification by column chromatography [silica gel; dioxane/methanol (1:1)], 4,9-dihydro-4-[(1-methyl-4-piperidinyl)-acetyl]-10H-thieno[3,4-b][1,5]benzodiazepin-10-one was obtained, m.p.: 184°-185° C. (ethyl acetate).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04424225 |
|---|
| Source dataset | uspto-grants-1984_01 |
|---|
| ORD ID | ord-2fa7a2ef1cb04f0faae6be463af577f2 |
|---|
| Source note | uspto-grants-1984_01 |
|---|